Patents for A61P 19 - Drugs for skeletal disorders (81,981)
02/2012
02/29/2012CN102178800B Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
02/29/2012CN102133271B Medicinal tea for curing gout
02/29/2012CN102058688B Qingpeng distillate for easing pain and reducing swelling and preparation method thereof
02/29/2012CN101822765B Quality inspection method of traditional Chinese medicine compound preparation with functions of tonifying kidney, strengthening bones, enriching blood and being beneficial to sperm
02/29/2012CN101703755B Gel for treating white-plus disease and preparation method thereof
02/29/2012CN101537002B Diacerein composition with good leaching property, and preparation and use thereof
02/29/2012CN101327288B Method for preparing Liaoyuanqili super fine powder
02/29/2012CN101244051B Actarit cyclodextrin, clathrate compound of cyclodextrin derivant and preparation thereof
02/28/2012US8124759 Inhibitors of protein kinases
02/28/2012US8124646 Substituted isoindoline-1,3-dione derivatives
02/28/2012US8124378 Murine zcytor17 ligand polynucleotides
02/28/2012US8124356 Methods of purifying zsig33
02/28/2012US8124134 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia
02/28/2012US8124122 Female hormone-containing patch
02/28/2012US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders
02/28/2012US8124074 Fusion proteins
02/28/2012US8123707 Method and apparatus for connective tissue treatment
02/28/2012CA2490622C Milk protein isolate and method for preparing same
02/28/2012CA2333951C Method for treating neurodegenerative disorders
02/23/2012WO2012024559A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
02/23/2012WO2012024242A1 Antibodies that bind myostatin, compositions and methods
02/23/2012WO2012024223A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
02/23/2012WO2012024161A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/23/2012WO2012022795A1 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor
02/23/2012WO2012022776A1 Substituted thiopenes or furans as estrogen receptor ligands
02/23/2012WO2011134679A3 Selected plant extracts for the treatment of inflammatory diseases
02/23/2012WO2011037957A3 Compositions and methods for bone repair, maintenance and regeneration
02/23/2012US20120046337 Novel Five-Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and Osteoarthritis Therapeutics
02/23/2012US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
02/23/2012US20120046327 Method for inhibiting the induction and formation of osteoclasts
02/23/2012US20120046326 Drug containing benzophenone derivative or its salt
02/23/2012US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity
02/23/2012US20120046322 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/23/2012US20120046320 Beta- and gamma-diketones and gamma-hydroxyketones as wnt/beta-catenin signaling pathway activators
02/23/2012US20120046311 Chemokine receptor antagonists and methods of use thereof
02/23/2012US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors
02/23/2012US20120046301 Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor
02/23/2012US20120046290 Inhibition of p38 kinase activity using substituted heterocyclic ureas
02/23/2012US20120046286 Novel Compounds
02/23/2012US20120046280 Novel heteropyrrole analogs acting on cannabinoid receptors
02/23/2012US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2012US20120046255 Non-steroidal compounds
02/23/2012US20120046246 Methods for treating osteoclast-related disease, compounds and compositions thereof
02/23/2012US20120046243 Aminopyridine- and Aminopyrimidinecarboxamides as CXCR2 Modulators
02/23/2012US20120046236 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
02/23/2012US20120046227 Designer osteogenic proteins
02/23/2012US20120046221 Albumin fusion proteins
02/23/2012US20120046219 Melanocortin receptor-specific peptides
02/23/2012US20120046217 TNF-alpha Antagonists Containing IGFBP5
02/23/2012US20120045503 Compositions And Methods For Wound Healing
02/23/2012US20120045488 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
02/23/2012US20120045484 Calcium phosphate/sulfate-based bone implant composition
02/23/2012US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045441 Methods of treating lung disease and other inflammatory diseases
02/23/2012US20120045440 Method of treating rheumatoid arthritis with an anti-il-6r antibody
02/23/2012US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012US20120045424 Assembly, device kit and method for preparing platelet-rich plasma (prp)
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012DE102010034699A1 Pyrimidinderivate Pyrimidine derivatives
02/23/2012CA2808798A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
02/23/2012CA2808382A1 Antibodies that bind myostatin, compositions and methods
02/23/2012CA2808307A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/23/2012CA2808276A1 Intravaginal devices, methods of making, and uses thereof
02/23/2012CA2807419A1 Diketones and hydroxyketones as catenin signaling pathway activators
02/22/2012EP2420568A2 Methods and compositions for treatment of bone defects with placental cell populations
02/22/2012EP2420567A2 Methods and compositions for treatment of bone defects with placental cell populations
02/22/2012EP2420490A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof
02/22/2012EP2420250A1 Anti-Syndecan-4 antibodies
02/22/2012EP2420239A2 Antiangiogenic agents
02/22/2012EP2420238A2 Anti-angiogenic agents
02/22/2012EP2420236A2 Anti-angiogenic agents
02/22/2012EP2420230A2 Antiangiogenic agents
02/22/2012EP2419133A1 Rspondin-3 inhibition in bone disorders
02/22/2012EP2419121A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
02/22/2012EP2419091A2 Nanochanneled device and related methods
02/22/2012EP1799268B1 Magnetic particles for therapy and diagnosis
02/22/2012EP1648494B1 Anti-angiogenetic agent and its use in cancer treatment
02/22/2012EP1626049B1 Microcrystal of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione
02/22/2012EP1534289B2 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus
02/22/2012CN102361979A Peptide capable of binding to immunoglobulin
02/22/2012CN102358880A Formula and production method of health care vinegar capable of treating rheumatism
02/22/2012CN102358730A Micromolecular methyl ethyl ketone (MEK) protein kinase inhibitor
02/22/2012CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors
02/22/2012CN102357241A Traditional Chinese medicine composition for dissolving blood stasis and dispelling cold and preparation method thereof
02/22/2012CN102357235A Pasty pharmaceutical composition and preparation method thereof
02/22/2012CN102357234A Cervical spondylosis treating pill
02/22/2012CN102357187A Traditional Chinese medicine composition for treating acute lumbar sprain
02/22/2012CN102357162A Bone vitalizing and pain relieving medicine
02/22/2012CN102357137A Garter snake and centipede pill
02/22/2012CN102357098A Pharmaceutical composition, uses and preparing method thereof
02/22/2012CN102356876A Health food for preventing and treating premature aging of women and preparation method thereof
02/22/2012CN102078588B 一种治疗骨质增生的中药联合制剂及其制备方法 A joint Chinese medicine and its preparation method of treating osteoarthritis
02/22/2012CN102058677B 一种治疗风湿性关节炎的中药组合物 A method of treating rheumatoid arthritis herbal composition
02/22/2012CN102008537B 一种祛风除湿的药酒 One kind of wine Qufengchushi
02/22/2012CN101991811B 一种治疗风湿关节疼痛、感冒头痛、脘腹疼痛、冻疮的中药组合物及其制备方法 A method of treating rheumatoid joint pain, flu, headache, abdominal pain, medicine composition and its preparation method frostbite
02/22/2012CN101983722B 一种用于防治关节软组织损伤及并发炎症的组合物 A method for prevention and treatment of joint and soft tissue injury and inflammation concurrent composition
02/22/2012CN101954055B 治疗骨质增生、腰椎间盘突出的外用药及其制备方法 Treatment of osteoarthritis, lumbar disc herniation outside the administration and its preparation method
02/22/2012CN101875922B 一种重组苛求芽孢杆菌胞内尿酸酶及其聚乙二醇修饰与应用 A recombinant Bacillus cells within demanding its PEGylated uricase and Applications
02/22/2012CN101856333B 头孢孟多酯钠冻干粉针制剂及其制备方法 Cefamandole ester sodium freeze-dried powder and its preparation method